NCT00055926View on ClinicalTrials.gov

CP-724,714 in Treating Patients With Metastatic Breast Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

December 31, 2004

Study Completion Date

May 31, 2005

Conditions
Breast Cancer
Interventions
DRUG

CP-724,714

Trial Locations (1)

90095-1781

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Jonsson Comprehensive Cancer Center

OTHER

NCT00055926 - CP-724,714 in Treating Patients With Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter